Successful sedation with remimazolam and alfentanil in a child susceptible to malignant hyperthermia: a case report
Abstract Background Malignant hyperthermia (MH) is a life-threatening autosomal-dominant disorder caused by mutations in the ryanodine receptor 1 (RYR1) gene, leading to calcium dysregulation in skeletal muscle. Patients with genetically confirmed MH susceptibility must strictly avoid volatile anest...
Saved in:
| Main Authors: | Kailai Zhu, Shuangwei Wu, Xianglin Hao, Chuanguang Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Anesthesiology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12871-025-03076-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alfentanil Enhanced the Sedation of Remimazolam During Anaesthesia Induction in Patients Undergoing Urological Day Surgery: A Randomised Controlled Trial
by: Lin Y, et al.
Published: (2025-07-01) -
Comparison of effect of remimazolam and propofol on respiration of patients under deep sedation for colonoscopy: a prospective multicenter randomized controlled trial
by: Zhengjia Wang, et al.
Published: (2025-04-01) -
Remimazolam in children: a comprehensive narrative review
by: Tom G. Hansen, et al.
Published: (2025-02-01) -
Remifentanil enhances the sedative effect of remimazolam during anesthesia induction in patients undergoing hysteroscopy: a randomized controlled trial
by: Zhengui Xie, et al.
Published: (2025-12-01) -
Remimazolam, a novel drug, for safe and effective endoscopic sedation
by: Jae Min Lee, et al.
Published: (2025-05-01)